Optimization of placebos for double-blind clinical trials -: Experience with a phytopharmaceutical

被引:0
|
作者
Knipschild, PG
Hörr, R
Oschmann, R
van Rossum, E
van Dongen, MCJM
机构
[1] Dr Willmar Schwabe GmbH & Co, Klin Forsch, D-76227 Karlsruhe, Germany
[2] Univ Maastricht, Abt Epidemiol, Maastricht, Netherlands
来源
PHARMAZEUTISCHE INDUSTRIE | 1999年 / 61卷 / 07期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The maintenance of double-blind conditions in placebo-controlled trials depends on the quality of the placebo preparation. The placebo should match the active substance-containing preparation as closely as possible, but it should not contain any substances that might themselves be pharmacologically active. Active substances characterized by a particular colour, taste, smell or other easily perceptible properties constitute a challenge to researchers. The way of developing a placebo that matches a phytopharmaceutical to a satisfactory extent is described and discussed.
引用
收藏
页码:653 / 655
页数:5
相关论文
共 50 条
  • [1] Optimization of placebos for double-blind clinical trials - Experience with a phytopharmaceutical
    Knipschild, PG
    Hoerr, R
    Oschmann, R
    van Rossum, E
    van Dongen, MCJM
    [J]. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (10): : 1033 - 1036
  • [2] DOUBLE-BLIND CLINICAL TRIALS
    MAGGS, R
    [J]. LANCET, 1974, 1 (7865): : 1048 - 1048
  • [3] Are ''double-blind'' trials truly ''double-blind?'' Implications for prospective clinical trials
    Rosman, NP
    Douglass, LM
    Paolini, JL
    [J]. ANNALS OF NEUROLOGY, 1996, 40 (02) : 64 - 64
  • [4] DOUBLE-BLIND CLINICAL-TRIALS
    HOFFER, A
    OSMOND, H
    [J]. JOURNAL OF NEUROPSYCHIATRY, 1961, 2 (05): : 221 - 227
  • [5] DOUBLE-BLIND TRIALS
    ADAMS, JG
    [J]. LANCET, 1976, 1 (7960): : 641 - 641
  • [6] DOUBLE-BLIND TRIALS
    VERE, DW
    CHAPUTDESAINTONGE, DM
    [J]. LANCET, 1976, 1 (7958): : 546 - 546
  • [7] DOUBLE-BLIND TRIALS
    NEWCOMBE, RG
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1990, 156 : 282 - 282
  • [8] Prospective, double-blind, seemingly ignored clinical trials
    Materson, BJ
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (01) : 76 - 78
  • [9] STATISTICS IN QUESTION - ASSESSING CLINICAL-TRIALS - DOUBLE-BLIND TRIALS
    GORE, SM
    [J]. BRITISH MEDICAL JOURNAL, 1981, 283 (6284): : 122 - 124
  • [10] BIAS IN DOUBLE-BLIND TRIALS
    GOTZSCHE, PC
    [J]. DANISH MEDICAL BULLETIN, 1990, 37 (04): : 329 - 336